These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 6161731

  • 21. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G, Santoro A, Bonfante V, Valagussa P.
    Cancer Treat Rep; 1982 Apr; 66(4):881-7. PubMed ID: 6176323
    [Abstract] [Full Text] [Related]

  • 22. [Combination chemotherapy of Hodgkin's disease with vincristine, cyclophosphamide, procarbazine, and prednisolone].
    Aiba K, Ogawa M, Inagaki J, Horikoshi N, Ezaki K, Inoue K, Dohmyo M, Nagata T, Miyamoto H, Kobayashi T, Kuraishi Y.
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1928-32. PubMed ID: 6897857
    [Abstract] [Full Text] [Related]

  • 23. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 24. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K, Utsumi M, Shimoyama M.
    Gan To Kagaku Ryoho; 1998 Dec 01; 25(14):2202-9. PubMed ID: 9881076
    [Abstract] [Full Text] [Related]

  • 25. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D.
    J Chemother; 1989 Jul 01; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Petera J, Macharová H, Pohanková R, Malír A, Coupek P, Konecný M, Patera J, Pecina J, Drbal J, Koukalová H, Vásová I.
    Neoplasma; 2000 Jul 01; 47(2):129-32. PubMed ID: 10985481
    [Abstract] [Full Text] [Related]

  • 28. Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
    Gobbi PG, Broglia C, Bertè R, Petrilli MP, Molica S, Angrilli F, Iannitto E, Ghirardelli ML, Di Renzo N, Cavanna L, Ascari E.
    Haematologica; 2000 Jul 01; 85(7):722-8. PubMed ID: 10897124
    [Abstract] [Full Text] [Related]

  • 29. Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
    Glick JH, Barnes JM, Bakemeier RF, Prosnitz LR, Bennett JM, Neiman RS, Costello W, Orlow EL.
    Cancer Treat Rep; 1982 Apr 01; 66(4):855-70. PubMed ID: 7042087
    [Abstract] [Full Text] [Related]

  • 30. [The chemotherapeutic treatment of advanced Hodgkin's disease].
    Epelbaum R, Haim N, Ben-Shahar M, Valtuch I, Faraggi D, Sharabi-Nov A, Ben-Arie Y, Cohen Y.
    Harefuah; 2001 Apr 01; 140(4):311-5, 367. PubMed ID: 11303395
    [Abstract] [Full Text] [Related]

  • 31. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
    Majhail NS, Weisdorf DJ, Defor TE, Miller JS, McGlave PB, Slungaard A, Arora M, Ramsay NK, Orchard PJ, MacMillan ML, Burns LJ.
    Biol Blood Marrow Transplant; 2006 Oct 01; 12(10):1065-72. PubMed ID: 17084370
    [Abstract] [Full Text] [Related]

  • 32. Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Prosnitz LR, Farber LR, Fischer JJ, Bertino JR.
    Radiology; 1973 Apr 01; 107(1):187-93. PubMed ID: 4689429
    [No Abstract] [Full Text] [Related]

  • 33. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R, Nomdedeu J, Brunet S.
    N Engl J Med; 1993 Apr 08; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract] [Full Text] [Related]

  • 34. [A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes].
    Ziółko E.
    Pol Merkur Lekarski; 1997 Jul 08; 3(13):8-9. PubMed ID: 9432303
    [Abstract] [Full Text] [Related]

  • 35. [Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
    Andrieu JM, Asselain B, Bayle C, Teillet F, Clot P, Dana M, Katz M, Brière J, Jacquillat C, Bernard J.
    Bull Cancer; 1981 Jul 08; 68(2):190-9. PubMed ID: 7016225
    [No Abstract] [Full Text] [Related]

  • 36. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS.
    J Clin Oncol; 1998 Mar 08; 16(3):1235. PubMed ID: 9508214
    [No Abstract] [Full Text] [Related]

  • 37. Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy.
    Timothy AR, Sutcliffe SB, Wrigley PF, Jones AE.
    Int J Radiat Oncol Biol Phys; 1979 Feb 08; 5(2):165-9. PubMed ID: 457468
    [No Abstract] [Full Text] [Related]

  • 38. Chemotherapy of Hodgkin's disease.
    Malpas JS.
    J R Coll Physicians Lond; 1980 Jan 08; 14(1):26-33. PubMed ID: 6160241
    [No Abstract] [Full Text] [Related]

  • 39. [Chemotherapy of Hodgkin's disease with drug combinations].
    Jacquillat C, Weil M, Goguel A, Schaison G, Delobel J, Gemon MF, Brunel-Kotschi R, Teillet F, Boiron M, Bernard J.
    Presse Med (1893); 1971 Mar 06; 79(12):513-8. PubMed ID: 5548259
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.